For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.

The natriuretic peptide BNP and the inactive N-terminal fragment of its precursor, NT-proBNP, are used for both diagnostic and prognostic purposes in patients with heart failure or those suspected of heart failure. Susan Stienen carries out research into NT-proBNP-guided therapy in acute decompensated heart failure patients.

Event details of Treatment of acute, decompensated heart failure
Date 22 March 2018
Time 12:00 -13:00
Location Agnietenkapel
Room Location

S. Stienen: NT-ProBNP-Guided Therapy in Acute Decompensated Heart Failure.

Supervisor

Prof. Y.M. Pinto

Co-supervisor

Dr W.E.M. Kok

Agnietenkapel

Room Location

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam

Entrance

This event is open to the public.